Clinical Trial Update: A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip [Phase 3]

View source ↗

Summary

A multi-center Phase 3 actual-use study completed evaluating the safety of CL 108 for moderate to severe acute pain associated with osteoarthritis of the knee o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• CL-108 (CL-108)

Snippet

Sponsor: Charleston Laboratories, Inc | Conditions: Pain, Nausea | Phase 3 | Status: COMPLETED